Scientific Industries（SCND）株式概要サイエンティフィック・インダストリーズ社は、標準的な卓上実験機器、重量・計測機器、バイオプロセス製品の設計、製造、マーケティングを米国、ドイツ、および国際的に行っている。 詳細SCND ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性5/6配当金0/6リスク分析意味のある時価総額がありません ( $8M )過去5年間で収益は年間1.6%減少しました。 キャッシュランウェイが1年未満である 株式の流動性は非常に低い すべてのリスクチェックを見るSCND Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW484,833 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINROAG484,833 investors already sharing narrativesYour Fair ValueUS$Current PriceUS$0.6740.3% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-16m11m2016201920222025202620282031Revenue US$3.0mEarnings US$394.5kAdvancedSet Fair ValueView all narrativesScientific Industries, Inc. 競合他社Sintx TechnologiesSymbol: NasdaqCM:SINTMarket cap: US$6.8mTrinity BiotechSymbol: NasdaqGS:TRIBMarket cap: US$7.3mBiomericaSymbol: NasdaqCM:BMRAMarket cap: US$5.1mNexalin TechnologySymbol: NasdaqCM:NXLMarket cap: US$10.1m価格と性能株価の高値、安値、推移の概要Scientific Industries過去の株価現在の株価US$0.6752週高値US$0.9852週安値US$0.30ベータ0.291ヶ月の変化7.78%3ヶ月変化24.74%1年変化16.14%3年間の変化-85.82%5年間の変化-93.01%IPOからの変化1,022.67%最新ニュースお知らせ • Dec 30Scientific Industries, Inc., Annual General Meeting, Jan 22, 2026Scientific Industries, Inc., Annual General Meeting, Jan 22, 2026. Location: x0aavfc8zqiyaj0hihrame1, meeting id: 852 9343 8455, United Statesお知らせ • Nov 20Scientific Industries, Inc. to Report Q3, 2025 Results on Nov 19, 2025Scientific Industries, Inc. announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Nov 19, 2025お知らせ • Nov 15Scientific Industries, Inc. announced delayed 10-Q filingOn 11/14/2025, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 19Scientific Industries, Inc. to Report Q2, 2025 Results on Aug 19, 2025Scientific Industries, Inc. announced that they will report Q2, 2025 results at 4:00 PM, US Eastern Standard Time on Aug 19, 2025お知らせ • Aug 15Scientific Industries, Inc. announced delayed 10-Q filingOn 08/14/2025, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 13Scientific Industries, Inc. to Report Q3, 2025 Results on May 13, 2025Scientific Industries, Inc. announced that they will report Q3, 2025 results After-Market on May 13, 2025最新情報をもっと見るRecent updatesお知らせ • Dec 30Scientific Industries, Inc., Annual General Meeting, Jan 22, 2026Scientific Industries, Inc., Annual General Meeting, Jan 22, 2026. Location: x0aavfc8zqiyaj0hihrame1, meeting id: 852 9343 8455, United Statesお知らせ • Nov 20Scientific Industries, Inc. to Report Q3, 2025 Results on Nov 19, 2025Scientific Industries, Inc. announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Nov 19, 2025お知らせ • Nov 15Scientific Industries, Inc. announced delayed 10-Q filingOn 11/14/2025, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 19Scientific Industries, Inc. to Report Q2, 2025 Results on Aug 19, 2025Scientific Industries, Inc. announced that they will report Q2, 2025 results at 4:00 PM, US Eastern Standard Time on Aug 19, 2025お知らせ • Aug 15Scientific Industries, Inc. announced delayed 10-Q filingOn 08/14/2025, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 13Scientific Industries, Inc. to Report Q3, 2025 Results on May 13, 2025Scientific Industries, Inc. announced that they will report Q3, 2025 results After-Market on May 13, 2025お知らせ • Nov 13Scientific Industries, Inc. to Report Q3, 2024 Results on Nov 15, 2024Scientific Industries, Inc. announced that they will report Q3, 2024 results Pre-Market on Nov 15, 2024お知らせ • Aug 15Scientific Industries, Inc. to Report Q2, 2024 Results on Aug 15, 2024Scientific Industries, Inc. announced that they will report Q2, 2024 results at 9:30 AM, US Eastern Standard Time on Aug 15, 2024お知らせ • May 12Scientific Industries, Inc. to Report Q1, 2024 Results on May 16, 2024Scientific Industries, Inc. announced that they will report Q1, 2024 results at 9:30 AM, US Eastern Standard Time on May 16, 2024お知らせ • Apr 17Scientific Industries, Inc. Announces Appointment of Michael Blechman to the Board of DirectorsScientific Industries, Inc. announced the appointment of Michael Blechman to the Board of Directors of SI effective April 12, 2024. Mr. Blechman filled a Board vacancy and replaces Mr. Marcus Frampton, who recently resigned, as a Class B director. Michael Blechman brings over three decades of experience in sales, marketing, operations and strategic planning. As CEO of Automated Control Concepts, Inc. ("ACC") he led the organization through 20 years of profitable operations and positive shareholder returns, culminating in a successful transaction with a private equity investor. While at ACC, Michael spearheaded their entry into the biotech product space with the introduction of the highly effective Lab Owl bioreactor control and information system.お知らせ • Apr 16Scientific Industries, Inc., Annual General Meeting, May 17, 2024Scientific Industries, Inc., Annual General Meeting, May 17, 2024, at 11:00 US Eastern Standard Time. Agenda: To elect two class c directors to the company's board of directors to serve until the company’s annual meeting of stockholders with respect to the year ending December 31, 2026 and until the election and qualification of their respective successors; to ratify the appointment of MAZARS USA LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2024; and to transact such other business as may properly come before the annual meeting and any adjournments or postponements thereof.お知らせ • Mar 08Scientific Industries and Scientific Bioprocessing Inc. Announce Board ChangesScientific Industries, Inc. announced the appointment of John Nicols to the Board of Directors of SI and Chairman of its wholly, owned subsidiary, Scientific Bioprocessing Inc., effective March 4, 2024. Mr. Nicols replaces Mr. John A. Moore as Chairman of SBI. Mr. John Nicols brings over three decades of experience in delivering sustained growth and value creation across diverse global businesses, from cutting-edge biotechnologies to traditional chemistry. He is the former president and CEO of Codexis, where he led the growth and transformation of Codexis into a leading synthetic biology company. From 2013 to 2022, Nicols grew Codexis' product sales nine-fold to exceed $100 million, commercializing dozens of new products across pharmaceutical, food and nutrition, and life science tools verticals. Prior to Codexis, Nicols held various executive roles spanning his 22 years at Albemarle Corp, where he grew their largest business unit to more than $1 billion in global sales. Nicols received a M.B.A. from the Massachusetts Institute of Technology and a B.S. degree in chemical engineering from the Polytechnic Institute of New York University. Mr. Nicols is a NACD Director Certified Board partner, and he currently serves as Chair of both Antheia, a synthetic biology-based producer for the pharmaceutical industry, and Solve M.E., a leading not-for-profit seeking cures for debilitating infection associated chronic diseases like ME/CFS and Long Covid.お知らせ • Nov 14Scientific Industries, Inc. to Report Q3, 2023 Results on Nov 14, 2023Scientific Industries, Inc. announced that they will report Q3, 2023 results After-Market on Nov 14, 2023お知らせ • Aug 12Scientific Industries, Inc. to Report Q2, 2023 Results on Aug 14, 2023Scientific Industries, Inc. announced that they will report Q2, 2023 results at 4:00 PM, US Eastern Standard Time on Aug 14, 2023お知らせ • Jun 15Scientific Industries Announces Retirement of Joseph G. Cremonese as Member of Board of DirectorsScientific Industries, Inc. announced that Joseph G. Cremonese, a member of the Company's board of directors is retiring and has therefore, resigned, from the Company's Board of Directors, effective June 13, 2023.お知らせ • May 12Scientific Industries, Inc. to Report Q1, 2023 Results on May 16, 2023Scientific Industries, Inc. announced that they will report Q1, 2023 results at 9:30 AM, US Eastern Standard Time on May 16, 2023お知らせ • Dec 21Scientific Industries, Inc., Annual General Meeting, Jan 27, 2023Scientific Industries, Inc., Annual General Meeting, Jan 27, 2023, at 11:00 US Eastern Standard Time. Agenda: To elect two class B directors to the company's board of directors to serve until the company’s annual meeting of stockholders with respect to the year ending December 31, 2025 and until the election and qualification of their respective successors; to ratify the appointment of Macias Gini and O’Connell LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2022; and to discuss other matters.お知らせ • Nov 30Scientific Industries Launches New VIVID(R) LITE Automated Pill CounterScientific Industries, Inc. announced the launch of a new automated pill counter product - VIVID LITE. The new VIVID LITE is built on a Company-patented counting algorithm that utilizes photo optical object recognition technology to count pills for pharmacies, pharmaceutical manufacturing, and packaging applications. Additional features and benefits of VIVID LITE include the ability to count virtually every type of available pill including translucent pills, assistance with identification of incorrect pills, large counting tray and dispensing tubes, and Wifi/Ethernet/USB capabilities in a space-saving model. The VIVID LITE provides superior counting accuracy, and will be produced in the Company's Bohemia, NYU.S. manufacturing facility. The Company has also re-launched a rebranded version of its original VIVID pill counter as the VIVID ONE. The VIVID ONE has been upgraded with a super-fast counting engine, ability to integrate with most popular pharmacy management systems, ability to count virtually every type of pill, and also incorporates the Company's proprietary VIVID PLUS cloud-based software, which will be free to the customer for the first year, and then available at an annual subscription. Among many of the benefits of VIVID PLUS are access to the Medispan® drug database, free automatic software updates, reporting and analytics, and tracking and tracing under GS1 standards for the new regulatory requirements for improved patient safety.お知らせ • Nov 12Scientific Industries, Inc. to Report Q1, 2023 Results on Nov 15, 2022Scientific Industries, Inc. announced that they will report Q1, 2023 results at 9:30 AM, US Eastern Standard Time on Nov 15, 2022お知らせ • Sep 29Scientific Industries, Inc. to Report Q4, 2022 Results on Sep 29, 2022Scientific Industries, Inc. announced that they will report Q4, 2022 results at 9:30 AM, US Eastern Standard Time on Sep 29, 2022お知らせ • Apr 14Scientific Industries, Inc Announces Executive ChangesEffective April 11, 2022, Scientific Industries, Inc. hired Reginald Averilla as its Chief Financial Officer, replacing Helena R. Santos in that role, which she had held since August 2002. Mr. Averilla brings to the Company over 10 years of financial accounting and management experience, including private and public company governance and mergers and acquisitions. From July 2020 to April 2022, Mr. Averilla served as VP Controller of Medical Knowledge Group, a privately held company that provides marketing solutions in the biopharmaceutical industry. From 2017 to July 2020, Mr. Averilla served as VP Controller for Film Expo Group, a privately held company that organizes events in the motion picture industry.お知らせ • Apr 06Scientific Industries, Inc. Announces Executive ChangesEffective April 1, 2022, by mutual agreement between the Scientific Industries, Inc., (Company) Mr. Reinhard Vogt and his affiliate Societt Reinhard and Noah Vogt AG o GmbH, the consulting agreement among them dated July 20, 2020, as amended, was terminated and, the ninety (90) day notice period required under the agreement was waived and the Company made a single payment to Mr. Vogt of the consulting fees that would otherwise have been payable by the Company during such notice period. In connection with such termination, Mr. Vogt resigned from his positions as a Class A Director of the Company's Board of Directors.お知らせ • Mar 04Scientific Industries, Inc. announced that it has received $3.022008 million in fundingScientific Industries, Inc. announced that it has entered into securities purchase agreement for the issuance of 549,456 common shares at issue price of $5.50 per share for gross proceeds of $3,022,008 on March 2, 2022. The company also issued warrants to purchase 274,727 common shares of the company at an exercise price of $5.50 per share for a period of 5 years from the closing of the transaction.お知らせ • Feb 15Scientific Industries, Inc. announced delayed 10-Q filingOn 02/14/2022, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Sep 29Scientific Industries, Inc. announced delayed annual 10-K filingOn 09/27/2021, Scientific Industries, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Feb 13Scientific Industries, Inc. announced delayed 10-Q filingOn 02/12/2021, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jan 23Scientific Industries, Inc., Annual General Meeting, Feb 26, 2021Scientific Industries, Inc., Annual General Meeting, Feb 26, 2021, at 11:00 US Eastern Standard Time. Agenda: To elect two Class C Directors to the Company's Board of Directors to serve until the Companys annual meeting of stockholders with respect to the year ending June 30, 2023 and until the election and qualification of their respective successors; to consider and act upon a proposal to approve an amendment to the Certificate of Incorporation of the Company; to consider and act upon a proposal to approve an amendment to the 2012 Stock Option Plan of the Company; to ratify the appointment of Nussbaum Berg Klein & Wolpow, CPAs LLP as the Companys independent registered public accounting firm for the fiscal year ending June 30, 2021; and to transact such other business.お知らせ • Jan 09Scientific Industries, Inc. Announces Resignation of Mr. John F.F. Watkins as A Class C DirectorScientific Industries, Inc. announced that On January 8, 2021, the Board accepted the resignation of Mr. John F.F. Watkins as a Class C Director. Mr. Watkins resignation was not the result of any dispute or disagreement with the Company. The Company will pay Mr. Watkins director fees through December 31, 2020.お知らせ • Nov 13Scientific Industries, Inc. announced delayed 10-Q filingOn 11/12/2020, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Sep 29Scientific Industries, Inc. announced delayed annual 10-K filingOn 09/28/2020, Scientific Industries, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.株主還元SCNDUS Medical EquipmentUS 市場7D-3.8%-2.7%0.8%1Y16.1%-20.6%20.5%株主還元を見る業界別リターン: SCND過去 1 年間で-20.6 % の収益を上げたUS Medical Equipment業界を上回りました。リターン対市場: SCNDは、過去 1 年間で20.5 % のリターンを上げたUS市場を下回りました。価格変動Is SCND's price volatile compared to industry and market?SCND volatilitySCND Average Weekly Movementn/aMedical Equipment Industry Average Movement8.4%Market Average Movement7.2%10% most volatile stocks in US Market16.6%10% least volatile stocks in US Market3.2%安定した株価: SCNDの株価は、 US市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のSCNDのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト195455Helena Santoswww.scientificindustries.comサイエンティフィック・インダストリーズ社は、標準的な卓上実験器具、重量・計測機器、バイオプロセス製品の設計、製造、マーケティングを米国、ドイツ、および国際的に行っている。同社は、試験管やビーカーなどの容器を回転カップなどのアタッチメントに載せて混合するボルテックスミキサーや、高速タッチミキサー、タイマー一体型ミキサー、細胞破砕機、ビーズビーター、マイクロプレートミキサー、プログラマブルボルテックスミキサー、2種類の大容量マルチベッセルボルテックスミキサー、オービタルシェーカーなどの各種ミキサーやシェーカーを提供している；多目的ローテーターとロッカー、そしてジーニーブランドの高/低プログラマブルマグネチックスターラー、4連高/低プログラマブルマグネチックスターラー、大容量マグネチックスターラー、4連汎用スターラー。また、Torbalブランドで薬局用、実験室用、工業用デジタルスケール、水分分析計、機械式および自動錠剤カウンター、フォースゲージ、テストスタンド製品、バイオプロセシングシステムとして、シェイクフラスコ内のバイオマスモニタリング用細胞増殖定量装置、シェイクフラスコ内の自動供給用液体注入システム、pHおよびDOモニタリング用各種コースターシステムおよびフロースルーセル、分析ソフトウェア、マルチパラメータセンサーおよび溶存酸素センサーピルを提供している。同社の製品は、大学、製薬会社、薬局、国立研究所、医療機器メーカー、その他研究室規模の研究を行う業界で研究目的に使用されている。同社は実験機器販売業者やエンドユーザー向けに電子商取引を通じて製品を販売している。サイエンティフィック・インダストリーズ社は1954年に設立され、ニューヨーク州ボヘミアに本社を置いている。もっと見るScientific Industries, Inc. 基礎のまとめScientific Industries の収益と売上を時価総額と比較するとどうか。SCND 基礎統計学時価総額US$8.04m収益（TTM）-US$6.58m売上高(TTM)US$5.34m1.5xP/Sレシオ-1.2xPER（株価収益率SCND は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計SCND 損益計算書（TTM）収益US$5.34m売上原価US$3.91m売上総利益US$1.43mその他の費用US$8.00m収益-US$6.58m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）-0.55グロス・マージン26.76%純利益率-123.18%有利子負債／自己資本比率0%SCND の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/16 01:57終値2026/07/13 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Scientific Industries, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Paul KnightKeyBanc Capital Markets Inc.
お知らせ • Dec 30Scientific Industries, Inc., Annual General Meeting, Jan 22, 2026Scientific Industries, Inc., Annual General Meeting, Jan 22, 2026. Location: x0aavfc8zqiyaj0hihrame1, meeting id: 852 9343 8455, United States
お知らせ • Nov 20Scientific Industries, Inc. to Report Q3, 2025 Results on Nov 19, 2025Scientific Industries, Inc. announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Nov 19, 2025
お知らせ • Nov 15Scientific Industries, Inc. announced delayed 10-Q filingOn 11/14/2025, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 19Scientific Industries, Inc. to Report Q2, 2025 Results on Aug 19, 2025Scientific Industries, Inc. announced that they will report Q2, 2025 results at 4:00 PM, US Eastern Standard Time on Aug 19, 2025
お知らせ • Aug 15Scientific Industries, Inc. announced delayed 10-Q filingOn 08/14/2025, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 13Scientific Industries, Inc. to Report Q3, 2025 Results on May 13, 2025Scientific Industries, Inc. announced that they will report Q3, 2025 results After-Market on May 13, 2025
お知らせ • Dec 30Scientific Industries, Inc., Annual General Meeting, Jan 22, 2026Scientific Industries, Inc., Annual General Meeting, Jan 22, 2026. Location: x0aavfc8zqiyaj0hihrame1, meeting id: 852 9343 8455, United States
お知らせ • Nov 20Scientific Industries, Inc. to Report Q3, 2025 Results on Nov 19, 2025Scientific Industries, Inc. announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Nov 19, 2025
お知らせ • Nov 15Scientific Industries, Inc. announced delayed 10-Q filingOn 11/14/2025, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 19Scientific Industries, Inc. to Report Q2, 2025 Results on Aug 19, 2025Scientific Industries, Inc. announced that they will report Q2, 2025 results at 4:00 PM, US Eastern Standard Time on Aug 19, 2025
お知らせ • Aug 15Scientific Industries, Inc. announced delayed 10-Q filingOn 08/14/2025, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 13Scientific Industries, Inc. to Report Q3, 2025 Results on May 13, 2025Scientific Industries, Inc. announced that they will report Q3, 2025 results After-Market on May 13, 2025
お知らせ • Nov 13Scientific Industries, Inc. to Report Q3, 2024 Results on Nov 15, 2024Scientific Industries, Inc. announced that they will report Q3, 2024 results Pre-Market on Nov 15, 2024
お知らせ • Aug 15Scientific Industries, Inc. to Report Q2, 2024 Results on Aug 15, 2024Scientific Industries, Inc. announced that they will report Q2, 2024 results at 9:30 AM, US Eastern Standard Time on Aug 15, 2024
お知らせ • May 12Scientific Industries, Inc. to Report Q1, 2024 Results on May 16, 2024Scientific Industries, Inc. announced that they will report Q1, 2024 results at 9:30 AM, US Eastern Standard Time on May 16, 2024
お知らせ • Apr 17Scientific Industries, Inc. Announces Appointment of Michael Blechman to the Board of DirectorsScientific Industries, Inc. announced the appointment of Michael Blechman to the Board of Directors of SI effective April 12, 2024. Mr. Blechman filled a Board vacancy and replaces Mr. Marcus Frampton, who recently resigned, as a Class B director. Michael Blechman brings over three decades of experience in sales, marketing, operations and strategic planning. As CEO of Automated Control Concepts, Inc. ("ACC") he led the organization through 20 years of profitable operations and positive shareholder returns, culminating in a successful transaction with a private equity investor. While at ACC, Michael spearheaded their entry into the biotech product space with the introduction of the highly effective Lab Owl bioreactor control and information system.
お知らせ • Apr 16Scientific Industries, Inc., Annual General Meeting, May 17, 2024Scientific Industries, Inc., Annual General Meeting, May 17, 2024, at 11:00 US Eastern Standard Time. Agenda: To elect two class c directors to the company's board of directors to serve until the company’s annual meeting of stockholders with respect to the year ending December 31, 2026 and until the election and qualification of their respective successors; to ratify the appointment of MAZARS USA LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2024; and to transact such other business as may properly come before the annual meeting and any adjournments or postponements thereof.
お知らせ • Mar 08Scientific Industries and Scientific Bioprocessing Inc. Announce Board ChangesScientific Industries, Inc. announced the appointment of John Nicols to the Board of Directors of SI and Chairman of its wholly, owned subsidiary, Scientific Bioprocessing Inc., effective March 4, 2024. Mr. Nicols replaces Mr. John A. Moore as Chairman of SBI. Mr. John Nicols brings over three decades of experience in delivering sustained growth and value creation across diverse global businesses, from cutting-edge biotechnologies to traditional chemistry. He is the former president and CEO of Codexis, where he led the growth and transformation of Codexis into a leading synthetic biology company. From 2013 to 2022, Nicols grew Codexis' product sales nine-fold to exceed $100 million, commercializing dozens of new products across pharmaceutical, food and nutrition, and life science tools verticals. Prior to Codexis, Nicols held various executive roles spanning his 22 years at Albemarle Corp, where he grew their largest business unit to more than $1 billion in global sales. Nicols received a M.B.A. from the Massachusetts Institute of Technology and a B.S. degree in chemical engineering from the Polytechnic Institute of New York University. Mr. Nicols is a NACD Director Certified Board partner, and he currently serves as Chair of both Antheia, a synthetic biology-based producer for the pharmaceutical industry, and Solve M.E., a leading not-for-profit seeking cures for debilitating infection associated chronic diseases like ME/CFS and Long Covid.
お知らせ • Nov 14Scientific Industries, Inc. to Report Q3, 2023 Results on Nov 14, 2023Scientific Industries, Inc. announced that they will report Q3, 2023 results After-Market on Nov 14, 2023
お知らせ • Aug 12Scientific Industries, Inc. to Report Q2, 2023 Results on Aug 14, 2023Scientific Industries, Inc. announced that they will report Q2, 2023 results at 4:00 PM, US Eastern Standard Time on Aug 14, 2023
お知らせ • Jun 15Scientific Industries Announces Retirement of Joseph G. Cremonese as Member of Board of DirectorsScientific Industries, Inc. announced that Joseph G. Cremonese, a member of the Company's board of directors is retiring and has therefore, resigned, from the Company's Board of Directors, effective June 13, 2023.
お知らせ • May 12Scientific Industries, Inc. to Report Q1, 2023 Results on May 16, 2023Scientific Industries, Inc. announced that they will report Q1, 2023 results at 9:30 AM, US Eastern Standard Time on May 16, 2023
お知らせ • Dec 21Scientific Industries, Inc., Annual General Meeting, Jan 27, 2023Scientific Industries, Inc., Annual General Meeting, Jan 27, 2023, at 11:00 US Eastern Standard Time. Agenda: To elect two class B directors to the company's board of directors to serve until the company’s annual meeting of stockholders with respect to the year ending December 31, 2025 and until the election and qualification of their respective successors; to ratify the appointment of Macias Gini and O’Connell LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2022; and to discuss other matters.
お知らせ • Nov 30Scientific Industries Launches New VIVID(R) LITE Automated Pill CounterScientific Industries, Inc. announced the launch of a new automated pill counter product - VIVID LITE. The new VIVID LITE is built on a Company-patented counting algorithm that utilizes photo optical object recognition technology to count pills for pharmacies, pharmaceutical manufacturing, and packaging applications. Additional features and benefits of VIVID LITE include the ability to count virtually every type of available pill including translucent pills, assistance with identification of incorrect pills, large counting tray and dispensing tubes, and Wifi/Ethernet/USB capabilities in a space-saving model. The VIVID LITE provides superior counting accuracy, and will be produced in the Company's Bohemia, NYU.S. manufacturing facility. The Company has also re-launched a rebranded version of its original VIVID pill counter as the VIVID ONE. The VIVID ONE has been upgraded with a super-fast counting engine, ability to integrate with most popular pharmacy management systems, ability to count virtually every type of pill, and also incorporates the Company's proprietary VIVID PLUS cloud-based software, which will be free to the customer for the first year, and then available at an annual subscription. Among many of the benefits of VIVID PLUS are access to the Medispan® drug database, free automatic software updates, reporting and analytics, and tracking and tracing under GS1 standards for the new regulatory requirements for improved patient safety.
お知らせ • Nov 12Scientific Industries, Inc. to Report Q1, 2023 Results on Nov 15, 2022Scientific Industries, Inc. announced that they will report Q1, 2023 results at 9:30 AM, US Eastern Standard Time on Nov 15, 2022
お知らせ • Sep 29Scientific Industries, Inc. to Report Q4, 2022 Results on Sep 29, 2022Scientific Industries, Inc. announced that they will report Q4, 2022 results at 9:30 AM, US Eastern Standard Time on Sep 29, 2022
お知らせ • Apr 14Scientific Industries, Inc Announces Executive ChangesEffective April 11, 2022, Scientific Industries, Inc. hired Reginald Averilla as its Chief Financial Officer, replacing Helena R. Santos in that role, which she had held since August 2002. Mr. Averilla brings to the Company over 10 years of financial accounting and management experience, including private and public company governance and mergers and acquisitions. From July 2020 to April 2022, Mr. Averilla served as VP Controller of Medical Knowledge Group, a privately held company that provides marketing solutions in the biopharmaceutical industry. From 2017 to July 2020, Mr. Averilla served as VP Controller for Film Expo Group, a privately held company that organizes events in the motion picture industry.
お知らせ • Apr 06Scientific Industries, Inc. Announces Executive ChangesEffective April 1, 2022, by mutual agreement between the Scientific Industries, Inc., (Company) Mr. Reinhard Vogt and his affiliate Societt Reinhard and Noah Vogt AG o GmbH, the consulting agreement among them dated July 20, 2020, as amended, was terminated and, the ninety (90) day notice period required under the agreement was waived and the Company made a single payment to Mr. Vogt of the consulting fees that would otherwise have been payable by the Company during such notice period. In connection with such termination, Mr. Vogt resigned from his positions as a Class A Director of the Company's Board of Directors.
お知らせ • Mar 04Scientific Industries, Inc. announced that it has received $3.022008 million in fundingScientific Industries, Inc. announced that it has entered into securities purchase agreement for the issuance of 549,456 common shares at issue price of $5.50 per share for gross proceeds of $3,022,008 on March 2, 2022. The company also issued warrants to purchase 274,727 common shares of the company at an exercise price of $5.50 per share for a period of 5 years from the closing of the transaction.
お知らせ • Feb 15Scientific Industries, Inc. announced delayed 10-Q filingOn 02/14/2022, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Sep 29Scientific Industries, Inc. announced delayed annual 10-K filingOn 09/27/2021, Scientific Industries, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Feb 13Scientific Industries, Inc. announced delayed 10-Q filingOn 02/12/2021, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jan 23Scientific Industries, Inc., Annual General Meeting, Feb 26, 2021Scientific Industries, Inc., Annual General Meeting, Feb 26, 2021, at 11:00 US Eastern Standard Time. Agenda: To elect two Class C Directors to the Company's Board of Directors to serve until the Companys annual meeting of stockholders with respect to the year ending June 30, 2023 and until the election and qualification of their respective successors; to consider and act upon a proposal to approve an amendment to the Certificate of Incorporation of the Company; to consider and act upon a proposal to approve an amendment to the 2012 Stock Option Plan of the Company; to ratify the appointment of Nussbaum Berg Klein & Wolpow, CPAs LLP as the Companys independent registered public accounting firm for the fiscal year ending June 30, 2021; and to transact such other business.
お知らせ • Jan 09Scientific Industries, Inc. Announces Resignation of Mr. John F.F. Watkins as A Class C DirectorScientific Industries, Inc. announced that On January 8, 2021, the Board accepted the resignation of Mr. John F.F. Watkins as a Class C Director. Mr. Watkins resignation was not the result of any dispute or disagreement with the Company. The Company will pay Mr. Watkins director fees through December 31, 2020.
お知らせ • Nov 13Scientific Industries, Inc. announced delayed 10-Q filingOn 11/12/2020, Scientific Industries, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Sep 29Scientific Industries, Inc. announced delayed annual 10-K filingOn 09/28/2020, Scientific Industries, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
